跳至主要内容
临床试验/NCT02364466
NCT02364466Unknown不适用

Multicenter Prospective Cohort Study of Peripheral T Cell Lymphoma

Korea Cancer Center Hospital18 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
18
主要终点
Febrile neutropenia

研究概览

简要总结

Prospective, observational cohort study of peripheral T cell lymphoma. Purpose is to investigate the complication including febrile neutropenia in the era of pegylated G-CSF prophylaxis.

详细描述

Prospective evaluation of frequencies of febrile neutropenia or infectious complications in a homogeneous population of patients with peripheral T cell lymphoma

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Treatment naive peripheral T cell lymphoma
  • Subtypes are as followings:
  • Anaplastic large cell lymphoma angioimmunoblastic T cell lymphoma Peripheral T cell lymphoma-NOS Enteropathy-associated T cell lymphoma Hepatosplenic T-cell lymphoma Subcutaneous panniculitis-like T-cell lymphoma Primary cutaneous gamma-delta T-cell lymphoma Primary cutaneous CD8+ aggressive epidermotropic lymphoma
  • Scheduled to receive chemotherapy of curative intent
  • 19 years old or over
  • Expected survival is more than 6 months
  • Informed consent

排除标准

  • Other histology than those described above
  • Extranodal NK/T cell lymphoma
  • Other than peripheral T cell lymphoma
  • Other combined malignancy
  • Previous history of chemotherapy or radiation therapy
  • No informed consent

结局指标

主要结局

Febrile neutropenia

时间窗: 2 years after the last enrollment

Incidence and severity of febrile neutropenia

次要结局

  • Infectious complication(2 years after the last enrollment)

研究者

发起方
Korea Cancer Center Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sujin Kang

CRA

Korea Cancer Center Hospital

研究点 (18)

Loading locations...

相似试验

Cohort of Peripheral T Cell Lymphoma | 临床试验